In a significant move within the biopharmaceutical industry, Comanche Biopharma, a clinical-stage company spearheading innovative therapy for preeclampsia, has announced the appointment of Allyson Felix to its Board of Directors. Felix is not only the most decorated American track and field athlete in history, holding 31 global medals from the Olympics and World Championships, but also the Co-Founder and President of Saysh, a company dedicated to crafting women-specific athletic footwear.
“We are thrilled to welcome Allyson to the Comanche Biopharma Board of Directors,” expressed Scott Johnson, MD, CEO of Comanche Biopharma. “Her diverse experience and unique perspective as a track legend, preeclampsia survivor, successful entrepreneur, and maternal health advocate will undoubtedly be invaluable to our work.”
Felix’s personal battle with preeclampsia has driven her commitment to addressing the devastating impacts of this disease and the stark disparities in maternal care, both domestically and internationally. She has been a powerful voice for improved maternal health and the rights of pregnant women, leveraging her prominent platform to amplify awareness and catalyze positive change.
“I am deeply honored to join the Board of Directors at Comanche Biopharma,” Felix said. “This is a passion project for me. I look forward to contributing to Comanche’s success and using my influence to boost preeclampsia awareness.”
Felix’s appointment equips Comanche Biopharma with a formidable ally in its mission to enhance maternal health on a global scale.
For further information, please contact Jove Oliver at Oliver Global Communications at +1 646 373 4702.